SCHEMBL14867264

SCHEMBL14867264

Cc1ccc(-c2[nH]c(=O)c3cc(C)ccc3c2Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
MEN1 O00255 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SERPINE1 P05121 1/20 0.40
PARP1 P09874 4/20 0.39
CDC25B P30305 1/20 0.39
UBE2I P63279 1/20 0.39
SAE1 Q9UBE0 1/20 0.39
UBA2 Q9UBT2 1/20 0.39
TNKS O95271 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867286 0.86 KDM4E (0.50) MAOAMAOBNPC1RAB9AKDM4E
SCHEMBL5017370 0.85 SERPINE1 (0.55) MAOAMAOBNPC1RAB9AHPGD
SCHEMBL14867316 0.82 SERPINE1 (0.53) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14867256 0.82 KDM4E (0.44) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14867254 0.81 PARP1 (0.46) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14867276 0.81 KDM4E (0.43) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14867269 0.78 ALB (0.41) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14867262 0.78 KDM4E (0.44) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL2429420 0.77 SERPINE1 (0.46) MAOAMAOBNPC1RAB9AKDM4E
SCHEMBL12324324 0.77 MAOB (0.51) MAOAMAOBMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883763-B2 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same UNIVERSITE JOSEPH FOURIER (FR) 2014-11-11 US disclosed
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME UNIVERSITE JOSEPH FOURIER (FR) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME GNAQ, HCCS, SDHA MAOA 2241/4885MAOB 1940/4885MEN1 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.